SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001654954-24-001699
Filing Date
2024-02-14
Accepted
2024-02-14 08:19:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT CamberPBYI13Ga2024.htm SC 13G/A 60668
2 JOINT FILING AGREEMENT CamberPBYI-a13g2024ex1.htm EX-1 4973
  Complete submission text file 0001654954-24-001699.txt   67472
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83367 | Film No.: 24632523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A